Showing 11,021 - 11,040 results of 31,447 for search '(( 10 ((mean decrease) OR (nn decrease)) ) OR ( 100 ((we decrease) OR (a decrease)) ))', query time: 0.93s Refine Results
  1. 11021
  2. 11022
  3. 11023

    Fig 3 - by Hyun-Jun Kim (1561153)

    Published 2021
    “…<p>A) Representative images of H&E stained C2C12 myotubes treated with Ni (scale bar = 100 μm). …”
  4. 11024
  5. 11025
  6. 11026

    S1 File - by Kazuyuki Hirooka (2635717)

    Published 2023
    “…</p><p>Methods</p><p>The ONH tissue area mean blur rate (MT) was evaluated in this single center, retrospective, cross-sectional study using LSFG. …”
  7. 11027
  8. 11028
  9. 11029
  10. 11030
  11. 11031
  12. 11032
  13. 11033
  14. 11034
  15. 11035
  16. 11036

    Fig 4 - by Hyun-Jun Kim (1561153)

    Published 2021
    “…<p>A) qPCR analysis of <i>Pax7</i>, <i>Myf5</i>, <i>Myod</i>, <i>Myog</i> and <i>Myh2</i> expression in differentiating C2C12 myoblasts treated with 150 nM, 300 nM or 600 nM Ni for 24 h. * = <i>p</i><0.05, ** = <i>p</i><0.01 and *** = <i>p</i><0.001 indicate significantly increased or decreased expression compared to untreated myoblasts. …”
  17. 11037
  18. 11038

    Baseline characteristics. by Si-Jing Chen (15350263)

    Published 2025
    “…In addition, the CBT-I group reported a greater decrease in depressive (adjusted difference −1.0 [−1.6 to −0.5]; Cohen’s <i>d</i> = 0.53; <i>p</i> < 0.001) and insomnia symptoms (−2.0 [−2.7 to −1.3], <i>d</i> = 0.78; <i>p</i> < 0.001) than the controls at post-intervention and throughout 6-month follow-up. …”
  19. 11039

    Secondary outcome results. by Si-Jing Chen (15350263)

    Published 2025
    “…In addition, the CBT-I group reported a greater decrease in depressive (adjusted difference −1.0 [−1.6 to −0.5]; Cohen’s <i>d</i> = 0.53; <i>p</i> < 0.001) and insomnia symptoms (−2.0 [−2.7 to −1.3], <i>d</i> = 0.78; <i>p</i> < 0.001) than the controls at post-intervention and throughout 6-month follow-up. …”
  20. 11040